<DOC>
	<DOCNO>NCT01395849</DOCNO>
	<brief_summary>The purpose post-marketing surveillance detect adverse drug reaction ( particularly clinically significant adverse drug reaction ) occur clinical setting , examine factor likely affect safety efficacy Japanese asthma patient treat fluticasone propionate salmeterol xinafoate .</brief_summary>
	<brief_title>Drug Use Investigation ADOAIR ( Fluticasone/Salmeterol )</brief_title>
	<detailed_description />
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Must use fluticasone salmeterol first time Patients hypersensitivity salmeterol fluticasone Patients infection salmeterol fluticasone effective Patients deep mycosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>